Outcomes for Hand and Foot Soft Tissue Sarcomas Treated with Limb Sparing Multimodal Therapy
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 17-001727
Sponsor Protocol Number: 17-001727
About this study
Goals:
-
Report and describe patient-reported functional outcomes for hand and foot soft tissue sarcomas treated with limb sparing surgery and radiation therapy.
-
Describe radiotherapy volumes for hand and foot soft tissue sarcomas treated with limb sparing surgery and radiation therapy.
-
Report local control outcomes for hand and foot soft tissue sarcomas treated with limb sparing surgery and radiation therapy.
-
Report survival outcomes for hand and foot soft tissue sarcomas treated with limb sparing surgery and radiation therapy.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
1) Patients must have a biopsy proven soft tissue sarcoma involving the hand or foot.
2) Patients must have received radiation therapy at Mayo Clinic, Rochester.
3) Age ≥18 years as of January 1, 2017.
Exclusion Criteria:
1) Absence of biopsy proven sarcoma involving the hand or foot.
2) Patients did not receive radiation therapy at Mayo Clinic, Rochester.
3) Age <18 years as of January 1, 2017.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Ivy Petersen, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available